|University ||American University, B.A., Justice, 2003|
|Law School||American University, Washington College of Law, J.D., 2006|
|Admitted||2007, New York and New Jersey|
Joshua Apfelroth is an associate in the Corporate Department of Cadwalader's New York office.
His practice involves public and private mergers and acquisitions, securities law and corporate finance. Josh represents clients in a wide range of complex transactions, including public and private mergers, acquisitions, divestitures, public and private securities offerings, proxy contests, tender offers, exchange offers and joint ventures.
Josh is admitted to practice in the State of New York.
Mergers and Acquisitions
· Elan Corporation, plc's spinoff of a substantial portion of its drug discovery business platform
· Towers Watson's acquisition of Extend Health, Inc.
· Pfizer's acquisition of King Pharmaceuticals, Inc.
· Pfizer's acquisition of Wyeth
· Trian funds in the acquisition by Triarc of Wendy's
· Nektar Therapeutics' asset sale to Royalty Pharma
· Six Flags' joint venture to acquire Dick Clark Productions, Inc.
· Bear Stearns' merger with JP Morgan
· Six Flags' sale of certain parks to Parc 7F-Operations and CNL Income Properties
· Credit Suisse USA, Inc.'s purchase of Lime Financial Services
· Pfizer's sale of Consumer Healthcare Products Business by Pfizer to Johnson & Johnson
· Lehman Brothers Inc., Banc of America Securities LLC, JP Morgan Securities LLC and Bear Stearns in their capacities as financial advisor in connection with various mergers and acquisitions transactions
· Deutsche Bank and other underwriters in connection with Air Products and Chemicals, Inc.'s issuance of €300 million senior unsecured notes
· Elan Corporation, plc. in its $381 million sale of ordinary shares of Alkermes plc and subsequent $170 million sale of its remaining ordinary shares of Alkermes plc
· Elan Corporation, plc in connection with its $600 million pursuant to Rule 144A of the Securities Act and its tender offer to purchase approximately $625 million of outstanding notes and related redemption of non-tendering notes
· Barclays and the other underwriters in connection with Lorillard Tobacco Company's issuance of $500 million senior unsecured notes
· Trian funds in its $166 million tender offer for common stock of Wendy's/Arby's Group, Inc.
· Pfizer in public offering and $13.5 billion public offering and $10.5 billion private placement to finance its acquisition of Wyeth
· Pfizer in its Consent Solicitation and Offer to Guarantee
· Bear Stearns in connection with the Bear Stearns Medium Term Note Program and Reverse Convertible Note Program
Documents by this lawyer on Martindale.com
M&A Update: Delaware Supreme Court Upholds Business Judgment Rule Review for Certain Controlling Stockholder Transactions with Dual Minority Protections
Joshua Apfelroth,Jason M. Halper,Gregory A. Markel,William P. Mills,Martin L. Seidel, March 20, 2014
On March 14, 2014, the Delaware Supreme Court upheld the Court of Chancery’s 2013 decision in In re MFW Shareholders Litigation, holding that in going-private mergers where there is a controlling stockholder, the use of both a truly independent special committee and a majority of the minority...
|Profile Visibility |
|#10,431 in weekly profile views out of 88,722 lawyers in New York, New York|
|#131,925 in weekly profile views out of 1,530,397 total lawyers Overall|